Behavioral conditioning with interferon beta-1a in humans

Physiology and Behavior

Volumn 84, Issue 5, 2005, Pages 807-814

  Goebel, Marion U ^a   Hübell, Diana ^a   Kou, Wei ^a   Janssen, Onno E ^a   Katsarava, Zaza ^a   Limmroth, Volker ^a   Schedlowski, Manfred ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

Behavioral conditioning; Cytokine; Immune responses; Interferon beta; One trial learning

Indexed keywords

BETA1A INTERFERON; INTERLEUKIN 6; NORADRENALIN; SODIUM CHLORIDE;

ADULT; ARTICLE; B LYMPHOCYTE; BEHAVIOR; BEHAVIOR CONDITIONING; BLOOD ANALYSIS; BODY TEMPERATURE; CONDITIONING; CONTROLLED STUDY; FLUID INTAKE; GRANULOCYTE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; LEARNING; LYMPHOCYTE COUNT; MALE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE;

EID: 18844461901     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2005.03.021     Document Type: Article

References (32)

1. R. Ader, and N. Cohen Behaviorally conditioned immunosuppression Psychosom Med 37 1975 333 340
2. M.S. Exton, J. Herklotz, J. Westermann, and M. Schedlowski Conditioning in the rat: an in-vivo model to investigate the molecular mechanisms and clinical implications of brain-immune communication Immunol Rev 184 2001 226 235
3. R. Ader Conditioned immunomodulation: research needs and directions Brain Behav Immun 17 2003 S51 S57
4. W. Klosterhalfen, and S. Klosterhalfen Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats Behav Neurosci 97 1983 663 666
5. M.S. Exton, S.B. von Hörsten, M. Schult, J. Vöge, T. Strubel, and S. Donath Behaviourally conditioned immunosuppression using cyclosporin A: central nervous system reduces IL-2 production via splenic innervation J Neuroimmunol 88 1998 182 191
6. M.S. Exton, C. Gierse, B. Meier, M. Mosen, Y. Xie, and S. Frede Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors J Neuroimmunol 131 2002 21 30
7. R. Ader, K. Kelly, J.A. Moynihan, L.J. Grota, and N. Cohen Conditioned enhancement of antibody production using antigen as the unconditioned stimulus Brain Behav Immun 7 1993 334 343
8. R.M. Gorczynski Conditioned enhancement of skin allografts in mice Brain Behav Immun 4 1990 85 92
9. A. Buske-Kirschbaum, C. Kirschbaum, H. Stierle, H. Lehnert, and D. Hellhammer Conditioned increase of natural killer cell activity (NKCA) in humans Psychosom Med 54 1992 123 132
10. D.L. Longo, P.L. Duffey, W.C. Kopp, M.P. Heyes, W.G. Alvord, and W.H. Sharfman Conditioned immune response to interferon-γ in humans Clin Immunol 90 1999 173 181
11. M.U. Goebel, A.E. Trebst, J. Steiner, Y. Xie, M.S. Exton, and S. Frede Behavioral conditioning of immunosuppression is possible in man FASEB J 16 2002 1869 1873
12. G.M. Asnis, R. De La Garza, S.R. Kohn, J.F. Reinus, M. Henderson, and J. Shah IFN-induced depression: a role for NSAIDs Psychopharmacol Bull 37 2003 29 50
13. M.U. Goebel, J. Baase, V. Pithan, M.S. Exton, B. Saller, and M. Schedlowski Acute interferon beta-1b administration alters hypothalamic- pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects Psychoneuroendocrinology 27 2002 881 892
14. M.E. Duddy, M.A. Armstrong, A.D. Crockard, and S.A. Hawkins Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosis J Neuroimmunol 101 1999 98 109
15. T. Kümpfel, T. Bergh, T. Pollmächer, F. Holsboer, and C. Trenkwlader Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS Neurology 55 2000 1231 1233
16. F. Nicoletti, R. DiMarco, F. Patti, P. Zaccone, M.R. L'Episcopo, and E. Reggio Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-β1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-γ without modifying those of IL-1β, IL-2, IL-4 and tumor necrosis factor-α Cytokine 12 1999 682 687
17. W.E. Nolten, D. Goldstein, M. Lindstrom, M.V. McKenna, I.H. Carlson, and D.L. Trump Effects of cytokines on the pituitary-adrenal axis in cancer patients J Interf Res 13 1993 349 357
18. Y. Ohno, M. Fujimoto, A. Nishimura, and N. Aoki Change of peripheral levels of pituitary hormones and cytokines after injection of interferon (IFN)-β in patients with chronic hepatitis C J Clin Endocrinol Metab 83 1998 3681 3687
19. L.K. Neilley, D.S. Goodin, D.E. Goodkin, and S.L. Hauser Side effect profile of interferon beta-1b in MS. Results of an open label trail Neurology 46 1996 552 554
20. R. Hiramoto, V. Ghanta, B. Solvason, J. Lorden, C.M. Hsueh, and C. Rogers Identification of specific pathways of communication between the CNS and NK cell system Life Sci 53 1993 527 540
21. U. Stockhorst, J.A. Wiener, S. Klosterhalfen, W. Klosterhalfen, C. Aul, and H.J. Steingruber Effects of overshadowing on conditioned nausea in cancer patients: an experimental study Physiol Behav 64 1998 743 753
22. F. Benedetti, A. Pollo, L. Lopiano, M. Lanotte, S. Vighetti, and I. Rainero Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses J Neurosci 23 2003 4315 4323
23. R. Hiramoto, C. Rogers, S. Demissie, C.M. Hsueh, N. Hiramoto, and J. Lorden The use of conditioning to probe for CNS pathways that regulate fever and NK cell activity Int J Neurosci 84 1996 229 245
24. L.J. Janz, J. Green-Johnson, L. Murray, C.Y. Vriend, D.M. Nance, and A.H. Greenberg Pavlovian conditioning of LPS-induced responses: effects on corticosterone, splenic NE, and IL-2 production Physiol Behav 59 1996 1103 1109
25. D.F. Bull, M.S. Exton, and A.J. Husband Acute-phase immune response: lipopolysaccharide-induced fever and sleep alterations are not simultaneously conditionable in the rat during the inactive (light) phase Physiol Behav 56 1994 143 149
26. M.S. Exton, D.F. Bull, and M.G. King Behavioral conditioning of lipopolysaccharide-induced anorexia Physiol Behav 57 1995 401 405
27. R. Oberbeck, A. Kromm, M.S. Exton, U. Schade, and M. Schedlowski Pavlovian conditioning of endotoxin-tolerance in rats Brain Behav Immun 17 2003 20 27
28. H.B. Solvason, V.K. Ghanta, S.J. Soong, C.F. Rogers, C.M. Hsueh, and N.S. Hiramoto A simple, single, trial-learning paradigm for conditioned increase in natural killer cell activity Proc Soc Exp Biol Med 199 1992 199 203
29. R.N. Hiramoto, C.F. Rogers, S. Demissie, C.M. Hsueh, N.S. Hiramoto, and J.F. Lorden Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain Int J Neurosci 92 1997 259 285
30. M.A. Segall, and L.S. Crnic A test of conditioned taste aversion with mouse interferon-alpha Brain Behav Immun 4 1990 223 231
31. C. Mormede, N. Castanon, C. Medina, and R. Dantzer Conditioned place aversion with interleukin-1beta in mice is not associated with activation of the cytokine network Brain Behav Immun 17 2003 110 120
32. C. Mormede, K. Palin, K.W. Kelley, N. Castanon, and R. Dantzer Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice Brain Behav Immun 18 2004 186 200